The FDA announced today, February 11, 2022, that it would wait for data on whether three doses of Pfizer’s coronavirus vaccine are effective in children younger than five before deciding to authorize a vaccine for the age group. The FDA will no longer meet next week to weigh the evidence and make a recommendation on […]
FDA Delays Action on COVID Shots for Young Children Read More »
We know that participating in a clinical research study can be a new experience for many, so we want to introduce you to some of the wonderful and kind staff that will take care of you. You’ve already met Dr. Sharp and our CEO Linda Schipani, and now we want to introduce you to other
Get to Know Our Clinical Research Family Read More »
Nashville’s News Channel 5 recently interviewed Clinical Research Associates, Inc. Medical Director Dr. Stephan Sharp to discuss the dangers posed by RSV both to children and adults, and about the vaccine clinical study. Read more about the RSV study and the need for a vaccine below. NASHVILLE, Tenn. (WTVF) — RSV vaccine trials have been
Researchers Looking for More Volunteers in RSV Vaccine Study Read More »
The Director’s Cut: With so much information available about vaccines, CRA Medical Director Dr. Stephen Sharp wants to help you cut through the clutter. Below, Dr. Sharp uses his professional expertise to break down exactly what a vaccine is, and help you understand how scientists research vaccines. At CRA, we want to help you make
How We Research Vaccines: The Director’s Cut Read More »
Before we get too far into 2022, we want to take a look back and remember the lessons of 2021. Please take a moment to read the note below from Clinical Research Associates, Inc. CEO Linda M. Schipani. Greetings from all of us at Clinical Research Associates! Like so many of you, we have lost
A Note From Clinical Research Associates CEO Read More »
WKRN News 2 recently reported that cases of Respiratory Syncytial Virus (RSV) have risen among adults this year, and that currently there is no RSV vaccine available. Fortunately, Clinical Research Associates, Inc. and other research sites around the world are working hard to study potential RSV vaccines. Additional volunteers are needed to help researchers do
With No RSV Vaccine Available, WKRN Reports RSV Cases Have Risen Among Adults Read More »
On Friday, Pfizer announced that it will expand ongoing clinical trials of its COVID-19 vaccine in children to include a third dose for patients as young as 6 months old. Clinical Research Associates, Inc. will be part of this study expansion. However, at this time we do not have instructions to begin this work. As
Third Dose for Pediatric Patients Read More »
NASVHILLE, TN (WSMV) – Next week will mark one year since the Pfizer COVID-19 vaccine was administered for the first time in Tennessee to local surgeon Dr. William Polk. A lot has changed since then, including boosters and a new variant, but one thing has stayed the same, and that’s Dr. Polk’s perspective on vaccinations.
One Year Since First Pfizer Vaccine in Tennessee Read More »
RSV (Respiratory Syncytial Virus) is traditionally considered a childhood infection, and it certainly infects and hospitalizes many children and infants each year in Tennessee. But, like many other viruses we get in childhood, it can return with a vengeance when we get older. The estimated average is for 177,000 hospitalizations and 14,000 deaths each year
RSV Cases in Tennessee on the Rise, Vaccine Needed Read More »
RSV: A Hidden Epidemic in Adults 60+ Original story from WATE: RSV: A Hidden Epidemic in Adults 60+ As COVID continues in Knoxville, most people who are age 60 and up — even those fully vaccinated against COVID-19 — don’t know they are at high risk for another deadly respiratory virus on the rise: RSV.
WATE: RSV A Hidden Epidemic in Adults 60+ Read More »
